Chronic Respiratory Diseases Treatment Market: Global Industry Analysis, 2016–2024, Mylan N.V., Teva Pharmaceutical Ltd., Sumitomo Dainippon Pharma Co.Ltd.
The global market for the chronic respiratory diseases treatment is fragmented into the drug class, route of administration, and distribution channel. On the basis of the drug class, the global market is segregated into corticosteroids, bronchodilators, monoclonal antibodies, antibiotics, mucolytic agents, leukotriene modifiers, and others. On the basis of the route of administration, the market is categorized into parenteral, oral, and inhalational. On the basis of the distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and mail-order...
View full press release